The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management […]
Recent Content
- Myosin wins $2M grant to advance brain cancer treatment MT-125
- In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
- Linvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myeloma
- Overt forms advisory board to guide ovarian cancer therapy push
- Flare of clonal hematopoiesis, TP53 expansion and prior melphalan drive post-CAR-T myeloid disorders in multiple myeloma
- Enhanced dynamic risk stratification of smoldering multiple myeloma
- Maximizing RRMM strategy time at doctor appointments
- Don’t underestimate organization’s importance in RRMM care
- Embrace the toughest RRMM conversations ASAP
- A lay of the land in evolving RRMM treatment options